|
We have developed iBioLaunchâ„¢ technology, a unique platform
for the accelerated development and manufacture of high value
proteins of immediate interest as product candidates.
Advantages of our technology include its speed and
applicability to a broad range of disease agents. This enables
us to target rapidly evolving disease agents and develop
products with high safety, potency and efficacy. While all
targets listed are not being pursued as product candidates,
the table below summarizes the breadth of applicability of the
iBioLaunchâ„¢ technology. |